Prevalence of aldosterone breakthrough in dogs receiving renin‐angiotensin system inhibitors for proteinuric chronic kidney disease.

MLA

Ames, Marisa K., et al. “Prevalence of Aldosterone Breakthrough in Dogs Receiving Renin‐angiotensin System Inhibitors for Proteinuric Chronic Kidney Disease.” Journal of Veterinary Internal Medicine, vol. 36, no. 6, Nov. 2022, pp. 2088–97. EBSCOhost, https://doi.org/10.1111/jvim.16573.

APA

Ames, M. K., Vaden, S. L., Atkins, C. E., Palerme, J., Langston, C. E., Grauer, G. F., Shropshire, S., Bove, C., & Webb, T. (2022). Prevalence of aldosterone breakthrough in dogs receiving renin‐angiotensin system inhibitors for proteinuric chronic kidney disease. Journal of Veterinary Internal Medicine, 36(6), 2088–2097. https://doi.org/10.1111/jvim.16573

Chicago

Ames, Marisa K., Shelly L. Vaden, Clarke E. Atkins, Jean‐Sebastien Palerme, Catherine E. Langston, Gregory F. Grauer, Sarah Shropshire, Christina Bove, and Tracy Webb. 2022. “Prevalence of Aldosterone Breakthrough in Dogs Receiving Renin‐angiotensin System Inhibitors for Proteinuric Chronic Kidney Disease.” Journal of Veterinary Internal Medicine 36 (6): 2088–97. doi:10.1111/jvim.16573.